T
Teresa Peláez
Researcher at Hospital General Universitario Gregorio Marañón
Publications - 143
Citations - 7018
Teresa Peláez is an academic researcher from Hospital General Universitario Gregorio Marañón. The author has contributed to research in topics: Aspergillus fumigatus & Clostridium difficile. The author has an hindex of 43, co-authored 142 publications receiving 6379 citations. Previous affiliations of Teresa Peláez include Complutense University of Madrid.
Papers
More filters
Journal ArticleDOI
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Patricia Muñoz,Emilio Bouza,Manuel Cuenca-Estrella,Jose María Eiros,María Jesús Pérez,Mar Sánchez-Somolinos,Cristina Rincón,Javier Hortal,Teresa Peláez +8 more
TL;DR: Treatment with a probiotic containing Saccharomyces boulardii (Ultralevura; Bristol-Myers Squibb) stopped the outbreak of infection and use of S. cerevisiae probiotics should be carefully reassessed, particularly in immunosuppressed or critically ill patients.
Journal ArticleDOI
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.
Jesús Guinea,Marta Torres-Narbona,Paloma Gijón,Patricia Muñoz,Francisco Pozo,Teresa Peláez,J. de Miguel,Emilio Bouza +7 more
TL;DR: A large series of patients with chronic obstructive pulmonary disease and probable invasive pulmonary aspergillosis (IPA) are described, and the risk factors and incidence of the disease in patients with isolation of Aspergillus from lower respiratory tract samples are described.
Journal ArticleDOI
Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin
Teresa Peláez,Luis Alcalá,Rodolfo Hernández Alonso,Marta Rodríguez-Créixems,Juan M. García-Lechuz,Emilio Bouza +5 more
TL;DR: Rates of resistance to metronidazole and vancomycin were higher among isolates from human immunodeficiency virus-infected patients, and molecular typing methods proved the absence of clonality among the isolates with decreased susceptibilities to the antimicrobials tested.
Journal ArticleDOI
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
Ana Espinel-Ingroff,Daniel J. Diekema,Annette W. Fothergill,Elizabeth M. Johnson,Teresa Peláez,M. A. Pfaller,Michael G. Rinaldi,Emilia Cantón,John D. Turnidge +8 more
TL;DR: Although ECVs do not predict therapy outcome as clinical breakpoints do, they may aid in detection of azole resistance (non-WT MIC) due to cyp51A mutations, a resistance mechanism in some Aspergillus spp.
Journal ArticleDOI
Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)
Ana Alastruey-Izquierdo,Emilia Mellado,Teresa Peláez,Javier Pemán,S. Zapico,M. Alvarez,J. L. Rodriguez-Tudela,Manuel Cuenca-Estrella +7 more
TL;DR: Antifungal resistance was more common among emerging species such as those of Scedosporium and Mucorales and also among cryptic species of Aspergillus, with 40% of these isolates showing resistance to all of the antIFungal compounds tested.